14 results
hematology diagnosis algorithm chemotherapy doac anticoagulation malignancy syndrome toxicity vte adultonset anthracycline apml cardiology cardiotoxicity classification copd cyp3a4 differentiation disease
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
►
 Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... VTE #Malignancy #Cancer ... Anticoagulation #Management ... #Hematology #Oncology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... limitation, further evaluation ... #Management #Pulmonary
Testicular Cancer - Treatment Related Toxicities Bleomycin, Cisplatin, Etoposide, lfosfamide Tinnitus & Hearing Loss Neurotoxicity Pulmonary Fibrosis Hypotension Nephrotoxicity Skin Hyperpigmentation Hemorrhagic Cystitis Myelosuppression Peripheral Neuropathy Ashley
Testicular Cancer ... - Treatment Related ... Neurotoxicity Pulmonary ... toxicology #Toxicities #pharmacology ... #oncology
Adult-Onset Still's Disease Clinical triad: Fever, Arthralgia/arthritis, Skin rash ± odynophagia + Biological inflammation: Increased neutrophils, Hyperferritinemia, decreased
hemopathies, solid cancers ... hepatitis • Pulmonary ... Disease #diagnosis #management ... #treatment #rheumatology
Eosinophilic Gastroenteritis: Treatment Options Based on Severity of the Disease Mild: • Trial of PPI • Trial
Gastroenteritis: Treatment ... strictures Severe + Concern ... for HES: • Hematology ... consult for evaluation ... #management #gastroenterology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
B-LNH), solid cancers ... Unknown cause Treatment ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary ... #rheumatology
Pulmonary Nodule Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
Pulmonary Nodule ... Evaluation is guided ... The treatment of ... Management options ... diagnosis of lung cancer
No results found for "Evolution pulmonary treatment slitlamp pharmacology cancer rheumatology management oncology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Evolution #pulmonary #treatment #slitlamp #pharmacology #cancer #rheumatology #management #oncology